Advanced Protein-Fragment Complementation Assay (PCA) Service

Principle Platform Workflow Application Advantage Related Services FAQ Online Inquiry

For over two decades, Creative Biolabs has been at the forefront of protein interaction analysis. As a trusted partner to the global scientific community, we offer a sophisticated suite of Protein-Fragment Complementation Assay (PCA) services, also known as split-protein complementation assays. Our platforms are engineered to provide robust, quantitative, and real-time analysis of protein-protein interactions (PPIs) directly within the complex milieu of living cells and even whole organisms. By harnessing the latest advancements in reporter technology, we empower researchers to unravel complex biological networks, validate drug targets, and screen for novel therapeutics with exceptional confidence.

Discuss Your Project Today

The Principle of Protein-Fragment Complementation Assays (PCA)

The Protein-Fragment Complementation Assay is a powerful and versatile method for the direct detection of protein-protein interactions in vivo. The core principle is elegant in its simplicity: a reporter protein is rationally dissected into two non-functional fragments. These fragments are then genetically fused to two proteins of interest, "X" and "Y".

If Protein X and Protein Y do not interact, the two reporter fragments remain separate and inactive.
If Protein X and Protein Y interact, they bring the reporter fragments into close proximity, facilitating their reassembly into a functional, active reporter protein.

The reconstitution of the reporter generates a measurable signal (e.g., luminescence, fluorescence, or cell survival) that is directly proportional to the strength and abundance of the protein-protein interaction.

Fig. 1 Principle of Fluc PCA. (OA Literature) . Fig. 1 Principle of Fluc PCA (A) Fluc is dissected into two parts, N-terminal domain and C-terminal domain.¹

Our State-of-the-Art PCA Technology Platforms

We offer a comprehensive selection of PCA systems, allowing us to select the optimal reporter for your specific cell type, protein localization, and experimental goals.

PCA System	Principle	Signal Type	Key Advantages	Best For
Split-Luciferase	Interaction reconstitutes a luciferase enzyme.	Luminescence	Highest sensitivity, wide dynamic range, low background, ideal for quantitative measurements.	Detecting weak/transient interactions, HTS, in vivo imaging.
Bimolecular Fluorescence Complementation (BiFC)	Interaction reconstitutes a fluorescent protein (GFP, YFP, mCherry).	Fluorescence	Direct visualization of PPI localization via microscopy, stable signal.	Subcellular localization studies, confirming interactions in specific compartments.
Split-Ubiquitin System (SUS)	Interaction reconstitutes ubiquitin, leading to the cleavage and release of a transcription factor.	Reporter Gene (e.g., LacZ, HIS3)	Excellent for studying membrane protein interactions (Type I, II, multi-spanning).	GPCRs, transporters, ion channels, receptor-ligand interactions.
Dihydrofolate Reductase (DHFR) PCA	Interaction reconstitutes the DHFR enzyme, conferring resistance to methotrexate.	Cell Survival	Simple, selection-based readout; suitable for large-scale library screening.	Validating large sets of interactions, drug discovery screening.

A Streamlined Workflow of Protein-Fragment Complementation Assay Service

We have meticulously designed our PCA service workflow to be transparent, efficient, and collaborative.

Step 1: Consultation & Project Design: In-depth discussion with our experts to define project goals and select the optimal PCA strategy.
Step 2: Construct Engineering: Gene synthesis of your proteins of interest and subcloning into our optimized PCA vectors (N- and C-terminal fusions).
Step 3: Cell Line & Transfection: Preparation and transfection/transduction of a suitable mammalian cell line (e.g., HEK293, CHO) or other model systems.
Step 4: Assay Validation & Optimization: Rigorous QC to confirm protein expression and optimize assay conditions (e.g., cell density, induction time) for maximal signal-to-background ratio.
Step 5: Screening & Data Acquisition: Execution of the assay, whether for single-pair validation or high-throughput screening of compounds or protein libraries.
Step 6: Data Analysis & Reporting: Comprehensive analysis of raw data, calculation of key parameters, and compilation of a publication-ready report.

Applications: Advancing Research Across Diverse Fields

Our PCA services are a versatile tool applicable to a wide array of research areas.

Mapping Cellular Signaling Pathways: Elucidate complex signaling cascades by systematically mapping interactions between kinases, phosphatases, adaptors, and their substrates.
GPCR and Ion Channel Research: Investigate GPCR dimerization, GPCR-arrestin binding, and the interaction of ion channel subunits in their native membrane environment using our specialized Split-Ubiquitin System.
Drug Discovery & Screening:
Target Validation: Confirm the direct interaction between a drug target and its binding partner.
High-Throughput Screening: Screen small molecule or biologic libraries to identify inhibitors or stabilizers of a specific PPI.
Mechanism of Action (MoA) Studies: Determine if a drug's effect is due to the disruption of a protein-protein interface.
Validating Other Interaction Data: Use PCA as an orthogonal method to confirm findings from Yeast Two-Hybrid (Y2H), Co-Immunoprecipitation (Co-IP), or computational predictions.
Biologics Research: Characterize antibody-antigen binding, or analyze the interactions of bispecific antibodies and CAR-T components.
In Vivo Studies: Extend your research from cell lines to whole organisms (e.g., mice) using our advanced bioluminescent PCA systems for real-time imaging of PPIs in a living context.

Why Choose Creative Biolabs for Your PCA Needs?

Our PCA services are not just an assay; they are a complete, end-to-end solution designed to deliver actionable insights.

Unmatched Sensitivity with Advanced Reporters: We have moved beyond conventional reporters. Our portfolio includes cutting-edge split-reporters, which offer signal intensities up to 100-fold greater than traditional options, enabling the detection of weak or transient interactions.
Diverse Technological Platforms: We don't believe in a one-size-fits-all approach. We tailor the assay to your specific biological question, offering a range of PCA systems.
High-Throughput Screening (HTS) Expertise: Our automated platforms are optimized for screening large compound libraries or validating numerous protein pairs, accelerating your discovery pipeline.
Quantitative & Kinetic Analysis: Go beyond simple "yes" or "no" answers. Our assays can be configured to provide quantitative data on interaction affinities (Kd) and real-time kinetic monitoring of interaction dynamics in response to stimuli.
Expertise in Complex Targets: With 20+ years of experience, our team has successfully executed projects involving challenging proteins, including GPCRs, ion channels, and transmembrane proteins.
Comprehensive Project Management: From initial consultation and construct design to data interpretation and a final detailed report, a dedicated Ph.D.-level scientist will guide your project every step of the way.

Explore Our Related Protein-protein Interaction Services

PCA is a powerful tool, often best utilized as part of a multi-faceted research strategy. Creative Biolabs offers a comprehensive portfolio of services that complement our PCA platform. Explore our full range of PPI services here: Protein-Protein Interaction (PPI) Assay Services

Let's discuss how our advanced Protein-Fragment Complementation Assay services can accelerate your project.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQ)

Q: Which PCA system is best for my project?

A: The best system depends on your specific research question. For the highest sensitivity and quantitative results, we recommend split-luciferase. For visualizing interaction location, BiFC is ideal. For membrane proteins, the Split-Ubiquitin system is superior. Contact our specialists for a free consultation to determine the optimal approach.

Q: Can PCA be used to determine binding affinity (Kd)?

A: Yes, under carefully controlled conditions where protein expression levels are measured, dose-response curves can be generated to estimate the apparent affinity of the interaction within the cellular environment.

Q: What is the typical turnaround time for a PCA project?

A: Turnaround time varies based on project complexity, ranging from 4-6 weeks for simple pair validation to 8-12 weeks for a full high-throughput screening campaign.

Q: What do I receive in the final report?

A: You will receive a comprehensive report including the detailed experimental protocol, all raw and processed data, graphical representations of the results, statistical analysis, and a full scientific interpretation of the findings by our expert team.

Reference

Ohmuro-Matsuyama, Yuki, Chan-I. Chung, and Hiroshi Ueda. "Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments." BMC biotechnology 13.1 (2013): 31. Distributed under Open Access license CC BY 2.0, without modification. https://doi.org/10.1186/1472-6750-13-31

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.